Condition
Chronic Kidney Disease (CKD) Stage 5
Total Trials
4
Recruiting
1
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 90/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
1 of 0 completed with results
Key Signals
1 with results0
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 3 (1)
Trial Status
Unknown1
Active Not Recruiting1
Recruiting1
Terminated1
Clinical Trials (4)
Showing 4 of 4 trials
NCT07465445Not ApplicableActive Not RecruitingPrimary
PD Catheter Survival: Modified Percutaneous vs Moncrief-Popovich
NCT05465044Not ApplicableRecruitingPrimary
Incremental Hemodialysis for Veterans in the First Year of Dialysis (IncHVets)
NCT04967547Not ApplicableUnknownPrimary
Effect of Pre-emptive Assessment of Self-care Peritoneal Dialysis (PD) Ability on PD Choice in Patients With Stage 5 Chronic Kidney Disease
NCT00616902Phase 3TerminatedPrimary
The PRIMO II Study: Paricalcitol Injection Benefits in Renal Failure Induced Cardiac Morbidity in Subjects With Chronic Kidney Disease (CKD) Stage 5
Showing all 4 trials